Gallbladder Cancer Clinical Trials

15 recruiting

Frequently Asked Questions

Common questions about Gallbladder Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 1

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

Intrahepatic CholangiocarcinomaGallbladder CarcinomaMetastatic Malignant Neoplasm in the Peritoneum+5 more
City of Hope Medical Center12 enrolled1 locationNCT05285358
Recruiting
Not Applicable

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Liver CancerBiliary Tract CancerColon Cancer+76 more
Cedars-Sinai Medical Center360 enrolled1 locationNCT04907643
Recruiting
Phase 2

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Biliary Tract CancerCholangiocarcinomaGallbladder Cancer+2 more
Case Comprehensive Cancer Center27 enrolled2 locationsNCT07146646
Recruiting

EULAT Eradicate GBC

Gallbladder CancerGallstone Disease
Centre Paul Strauss15,000 enrolled36 locationsNCT06192719
Recruiting

Integrated Cancer Repository for Cancer Research

Breast CancerLiver CancerEsophageal Cancer+47 more
University of Nebraska999,999 enrolled45 locationsNCT02012699
Recruiting
Not Applicable

STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy

Gallbladder CancerCholecystitisCholelithiasis
Helsinki University Central Hospital850 enrolled1 locationNCT06123117
Recruiting

Bile Omics for Diagnosing Indeterminate Biliary Strictures

Pancreatic CancerCholangiocarcinomaGallbladder Cancer and Extrahepatic Cholangiocarcinoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine260 enrolled1 locationNCT07007832
Recruiting
Phase 2Phase 3

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

Gallbladder Cancer
Banaras Hindu University56 enrolled1 locationNCT05833815
Recruiting

NGS in Gallbladder Cancer and Response to Treatment

Gallbladder Cancer
Banaras Hindu University100 enrolled1 locationNCT05404347
Recruiting
Not Applicable

The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer

Gallbladder Cancer
Saint Vincent's Hospital, Korea88 enrolled1 locationNCT02920554
Recruiting
Phase 2

A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs

Unresectable Gallbladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University37 enrolled1 locationNCT06423170
Recruiting

Quebec Pancreas Cancer Study

Pancreatic CancerPancreas CancerHereditary Cancer+8 more
George Zogopoulos2,000 enrolled1 locationNCT04104230
Recruiting

The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer

CholangiocarcinomaPancreas CancerGallbladder Cancer
Samsung Medical Center1,000 enrolled1 locationNCT03637569
Recruiting
Phase 2

Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer

Gallbladder CancerInitially Unresectablethe First Line Treatment
Lu Wang, MD, PhD50 enrolled1 locationNCT05757336
Recruiting

Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer

Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
Herlev and Gentofte Hospital500 enrolled1 locationNCT05184400